{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:40:45Z","timestamp":1768272045797,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA74861"],"award-info":[{"award-number":["R01 CA74861"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA051008"],"award-info":[{"award-number":["P30 CA051008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007303","name":"Jess and Mildred Fisher Center for Familial Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10549-019-05515-2","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T13:02:21Z","timestamp":1577883741000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients"],"prefix":"10.1007","volume":"180","author":[{"given":"Mara","family":"Tynan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth N.","family":"Peshkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawna","family":"Willey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiddis B.","family":"Valdimarsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne C.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Jandorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Heinzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-5413","authenticated-orcid":false,"given":"Marc D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"issue":"9","key":"5515_CR1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975","journal-title":"JAMA"},{"issue":"7","key":"5515_CR2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamasurg.2017.0115","volume":"152","author":"R Nash","year":"2017","unstructured":"Nash R, Goodman M, Lin CC, Freedman RA, Dominici LS, Ward K et al (2017) State variation in the receipt of a contralateral prophylactic mastectomy among women who received a diagnosis of invasive unilateral early-stage breast cancer in the United States, 2004\u20132012. JAMA Surg 152(7):648\u2013657","journal-title":"JAMA Surg"},{"issue":"3","key":"5515_CR3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","volume":"265","author":"SM Wong","year":"2017","unstructured":"Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265(3):581\u2013589","journal-title":"Ann Surg"},{"issue":"3","key":"5515_CR4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","volume":"152","author":"R Jagsi","year":"2017","unstructured":"Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC et al (2017) Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg 152(3):274\u2013282","journal-title":"JAMA Surg"},{"issue":"1","key":"5515_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","volume":"150","author":"KL Kummerow","year":"2015","unstructured":"Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150(1):9\u201316","journal-title":"JAMA Surg"},{"issue":"16","key":"5515_CR6","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","volume":"29","author":"TA King","year":"2011","unstructured":"King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29(16):2158\u20132164","journal-title":"J Clin Oncol"},{"issue":"6","key":"5515_CR7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","volume":"149","author":"ST Hawley","year":"2014","unstructured":"Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ et al (2014) Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg 149(6):582\u2013589","journal-title":"JAMA Surg"},{"issue":"8","key":"5515_CR8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","volume":"3","author":"M Yi","year":"2010","unstructured":"Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do K-A et al (2010) Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Philadelphia, Pa.) 3(8):1026\u20131034","journal-title":"Cancer Prev Res (Philadelphia, Pa.)"},{"issue":"12","key":"5515_CR9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2017.76.2369","volume":"36","author":"SJ Katz","year":"2018","unstructured":"Katz SJ, Ward KC, Hamilton AS, McLeod MC, Wallner LP, Morrow M et al (2018) Gaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancer. J Clin Oncol 36(12):1218\u20131224","journal-title":"J Clin Oncol"},{"issue":"15","key":"5515_CR10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A et al (2019) Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol 37(15):1305\u20131315","journal-title":"J Clin Oncol"},{"issue":"35","key":"5515_CR11","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887\u20135892","journal-title":"J Clin Oncol"},{"issue":"23","key":"5515_CR12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416","journal-title":"JAMA"},{"issue":"3","key":"5515_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WLJ, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MBE et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159\u2013164","journal-title":"N Engl J Med"},{"issue":"2","key":"5515_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77\u201384","journal-title":"N Engl J Med"},{"issue":"6","key":"5515_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, Lvt V, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22(6):1055\u20131062","journal-title":"J Clin Oncol"},{"issue":"1","key":"5515_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","volume":"140","author":"DGR Evans","year":"2013","unstructured":"Evans DGR, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I et al (2013) Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat 140(1):135\u2013142","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5515_CR17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.29032","volume":"136","author":"BAM Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BAM, Rookus MA, Aalfs CM, Ausems MGEM, Coll\u00e9e JM, Jansen L et al (2015) Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer 136(3):668\u2013677","journal-title":"Int J Cancer"},{"key":"5515_CR18","first-page":"g226","volume":"348","author":"K Metcalfe","year":"2014","unstructured":"Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N et al (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ (Clinical Research ed.) 348:g226\u2013g226","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"10","key":"5515_CR19","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","volume":"22","author":"MD Schwartz","year":"2004","unstructured":"Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T et al (2004) Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22(10):1823\u20131829","journal-title":"J Clin Oncol"},{"issue":"3","key":"5515_CR20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10549-018-4773-3","volume":"170","author":"MD Schwartz","year":"2018","unstructured":"Schwartz MD, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R et al (2018) Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Res Treat 170(3):517\u2013524","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5515_CR21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2014.05.028","volume":"134","author":"E Lokich","year":"2014","unstructured":"Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J (2014) Preoperative genetic testing affects surgical decision making in breast cancer patients. Gynecol Oncol 134(2):326\u2013330","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5515_CR22","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/cam4.1519","volume":"7","author":"N Elsayegh","year":"2018","unstructured":"Elsayegh N, Webster RD, Gutierrez Barrera AM, Lin H, Kuerer HM, Litton JK et al (2018) Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer. Cancer Med 7(6):2718\u20132726","journal-title":"Cancer Med"},{"issue":"3","key":"5515_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.amjsurg.2011.04.001","volume":"202","author":"M Howard-McNatt","year":"2011","unstructured":"Howard-McNatt M, Schroll RW, Hurt GJ, Levine EA (2011) Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg 202(3):298\u2013302","journal-title":"Am J Surg"},{"issue":"2","key":"5515_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-017-4123-x","volume":"162","author":"JG Hamilton","year":"2017","unstructured":"Hamilton JG, Genoff MC, Salerno M, Amoroso K, Boyar SR, Sheehan M et al (2017) Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1\/2 mutation noncarriers with newly diagnosed breast cancer. Breast Cancer Res Treat 162(2):297\u2013306","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"5515_CR25","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1245\/s10434-015-4745-3","volume":"22","author":"F Wang","year":"2015","unstructured":"Wang F, Amara D, Peled AW, Sbitany H, Foster RD, Ewing CA et al (2015) Negative genetic testing does not deter contralateral prophylactic mastectomy in younger patients with greater family histories of breast cancer. Ann Surg Oncol 22(10):3338\u20133345","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"5515_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10549-006-9423-5","volume":"104","author":"KD Graves","year":"2007","unstructured":"Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD (2007) Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 104(3):321\u2013329","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"5515_CR27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/jso.23307","volume":"107","author":"L King","year":"2013","unstructured":"King L, O'Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S et al (2013) Intentions for bilateral mastectomy among newly diagnosed breast cancer patients. J Surg Oncol 107(7):772\u2013776","journal-title":"J Surg Oncol"},{"issue":"11","key":"5515_CR28","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"3","key":"5515_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"M Horowitz","year":"1979","unstructured":"Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41(3):209\u2013218","journal-title":"Psychosom Med"},{"issue":"3","key":"5515_CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","volume":"13","author":"LR Derogatis","year":"1983","unstructured":"Derogatis LR, Melisaratos N (1983) The brief symptom inventory: an introductory report. Psychol Med 13(3):595\u2013605","journal-title":"Psychol Med"},{"issue":"3","key":"5515_CR31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570\u2013579","journal-title":"J Clin Oncol"},{"key":"5515_CR32","unstructured":"SAS Institute I. SAS Campus Drive, Cary, North Carolina 27513, USA"},{"issue":"4","key":"5515_CR33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jamcollsurg.2017.12.037","volume":"226","author":"HJ Pederson","year":"2018","unstructured":"Pederson HJ, Gopalakrishnan D, Noss R, Yanda C, Eng C, Grobmyer SR (2018) Impact of multigene panel testing on surgical decision making in breast cancer patients. J Am Coll Surg 226(4):560\u2013565","journal-title":"J Am Coll Surg"},{"key":"5515_CR34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.7150\/jca.11710","volume":"6","author":"N Elsayegh","year":"2015","unstructured":"Elsayegh N, Profato J, Barrera AMG, Lin H, Kuerer HM, Ardic C et al (2015) Predictors that influence election of contralateral prophylactic mastectomy among women with ductal carcinoma in situ who are BRCA-negative. J Cancer 6:610\u2013615. https:\/\/doi.org\/10.7150\/jca.11710","journal-title":"J Cancer"},{"issue":"6","key":"5515_CR35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1188\/15.CJON.764-768","volume":"19","author":"B Jerome-D'Emilia","year":"2015","unstructured":"Jerome-D'Emilia B, Suplee PD, D'Emilia I (2015) Why women are choosing bilateral mastectomy. Clin J Oncol Nurs 19(6):764\u2013768","journal-title":"Clin J Oncol Nurs"},{"issue":"8","key":"5515_CR36","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1245\/s10434-017-5856-9","volume":"24","author":"MCA Donovan","year":"2017","unstructured":"Donovan MCA, Bao MJ, Gangi MA, Amersi MF, Zhang MX, Giuliano MAE et al (2017) Bilateral mastectomy as overtreatment for breast cancer in women age forty years and younger with unilateral operable invasive breast cancer. Ann Surg Oncol 24(8):2168\u20132173","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"5515_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surge.2014.02.005","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Kamali Polat A, Johnson R, McGuire KP (2014) Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon? Surgeon 12(6):316\u2013322","journal-title":"Surgeon"},{"issue":"6","key":"5515_CR38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamaoncol.2015.5941","volume":"2","author":"SM Rosenberg","year":"2016","unstructured":"Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S et al (2016) BRCA1 and BRCA2 mutation testing in young women with breast cancer. JAMA Oncol 2(6):730\u2013736","journal-title":"JAMA Oncol"},{"issue":"3","key":"5515_CR39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/PRS.0000000000001044","volume":"135","author":"S Agarwal","year":"2015","unstructured":"Agarwal S, Kidwell KM, Kraft CT, Kozlow JH, Sabel MS, Chung KC et al (2015) Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg 135(3):661\u2013670","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"5515_CR40","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1245\/s10434-014-3712-8","volume":"21","author":"A Ashfaq","year":"2014","unstructured":"Ashfaq A, McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, McLaughlin SA et al (2014) Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy. Ann Surg Oncol 21(9):2934\u20132940","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"5515_CR41","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2018.78.6442","volume":"36","author":"PA Parker","year":"2018","unstructured":"Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM et al (2018) Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol 36(25):2630\u20132638","journal-title":"J Clin Oncol"},{"issue":"12","key":"5515_CR42","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1245\/s10434-018-6581-8","volume":"25","author":"KA Theobald","year":"2018","unstructured":"Theobald KA, Susswein LR, Marshall ML, Roberts ME, Mester JL, Speyer D et al (2018) Utility of expedited hereditary cancer testing in the surgical management of patients with a new breast cancer diagnosis. Ann Surg Oncol 25(12):3556\u20133562","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"5515_CR43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamaoncol.2018.0644","volume":"4","author":"AW Kurian","year":"2018","unstructured":"Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I et al (2018) Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol 4(8):1066\u20131072","journal-title":"JAMA Oncol"},{"key":"5515_CR44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gim.2014.125","volume":"17","author":"M Butrick","year":"2014","unstructured":"Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW et al (2014) Disparities in uptake of BRCA1\/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17:467","journal-title":"Genet Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05515-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:21:15Z","timestamp":1722262875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05515-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5515"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05515-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"8 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Boards of all participating sites. The study complies with all current laws of the USA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}